A recent mental health study in Canada highlights the burden that many people with a meningioma face. It reveals key figures relating to depression and anxiety, and issues a call to action for the clinical brain cancer community.
What are the details of the study?
Previous explorations of the psychological burden of brain tumours have focused largely on high-grade glioma. By contrast, our knowledge of how people with tumours such as meningioma are affected psychologically has remained limited.
This study aimed to identify the kind of mental health burdens meningioma patients undergo, bringing awareness to potential gaps in patient care.
The team utilised the Hospital Anxiety and Depression Scale to collect data on the experiences of those involved, as well as some more intricate mathematical tools to detail trends and patterns. The results of the study revealed some consistent themes.
What were the results?
30 patients were included in the study with 20 of them being women. The average age was 56, and the average time since diagnosis was 38 months. 14 had received surgery, whilst the rest were being treated conservatively under observation.
It was found that 28.6% of those who had surgery experienced mild to severe anxiety symptoms. Whilst among those who hadn’t had surgery, this number was even larger with 50% experiencing anxiety. When it came to mild to severe symptoms of depression, 7.14% among the surgery cohort were affected. For those under observation, 6.25% were affected by these symptoms.
These findings are a step towards improvements in healthcare for meningioma patients and put a focus on the need and importance of mental health support and patient-centred care for our community.
To read more scientific information regarding the study, click here.
Want to receive all the latest research straight to your inbox?
Sign-up our curated, jargon-free weekly research newsletter. Click here to fill out our contact form and select ‘research’ to opt into our research newsletter.
Get involved with research…
If you would like to use your experience and insight to support clinical research, consider signing up to be a PRIME advocate for brainstrust.
If you or someone you love is living with a brain tumour and have any questions around this latest news, or want to access support, give us a call on 01983 292 405 or email email@example.com. You can also visit our little brainstrust website which features support for children affected by brain tumour.